The Senate Health and Human Services Committee signed off on a bill Tuesday that would allow patients to bypass insurance policies requiring them to try cheaper drugs before moving on to more expensive ones.
The committee unanimously approved the legislation requiring insurers, pharmacy benefit managers and utilization review organizations to have exceptions for step therapy protocols.
Lawmakers also approved bills that would:
· allow properly trained pharmacists to immunize patients younger than six who have a prescription for a vaccine.
· allow Wisconsin to continue to participate in a an interstate licensure compact that lets doctors more easily practice in other states.
· eliminate a law requiring distributors that provide patients with in-home dialysis supplies to obtain pharmacist licenses.
Doctor Day 2019 is fast approaching and it’s important that physicians like YOU participate in our unique-to-Wisconsin, annual multi-specialty advocacy event in Madison on Wednesday, May 1, 2019. As always, Doctor Day is a jointly-sponsored event that includes more than a dozen Wisconsin specialty societies and WMS.
As in past years, we strive to invite leading Wisconsin politicians or health policy experts to speak before Doctor Day to keep our attendees attuned to the latest in Wisconsin politics, and healthcare law and policy.
Attorney Guy DuBeau (Axley, Brynelson, SC), who serves as counsel to several special societies, will provide a legal update including discussion of the 2018 Mayo v. IPFCF decision (medical malpractice damage caps), current Wisconsin marijuana law and proposals, and physician non-compete agreements.
Each participating organization is invited to provide an “issue paper” to be left with lawmakers during the afternoon’s Legislative Visits, describing the particular organization and the organization’s key policy or legislative issues. Due to the unique nature of Doctor Day’s multi-specialty approach, and the limited time for each meeting with lawmakers, as always our attendees will be asked to jointly advocate for some key and politically timely health issues. During the morning General Session, lobbyists representing the participating organizations will lead briefings on these key Advocacy Issues, including:
Doctor Day will again conclude with the ever-popular Doctor Day Reception. This year, the reception will be held at a new and larger venue: Madison’s, a popular restaurant and bar located one block off the Square at 119 King Street, providing our attendees a casual opportunity to mingle and debrief with colleagues from a variety of medical specialties.
The tentative schedule and online registration are available at www.WIDoctorDay.org.
In just six years, Doctor Day has grown from just over 100 to nearly 500 attendees – but we need you to maintain that growth. As a Wisconsin physician, Doctor Day is the best way for you to let Wisconsin lawmakers know their physician-constituents are aware and care about what they are doing in Madison. There is no cost to attend Doctor Day, so please register today.
About 30 percent of graduating medical students will remain in Wisconsin for their residencies, according to the state’s two medical schools.
More than 400 Wisconsin Medical students found out where they’re heading for residencies earlier this month when the National Resident Matching Program released its results.
At the Medical College of Wisconsin, 33 percent of the 224 students who obtained positions are remaining in state. The top picks for specialties were internal medicine, pediatrics and family medicine.
The Wisconsin Medical Society plans to create a center focused on fighting physician burnout this year as well as pursue legislation to create a physician health program, according to a recent report showing more than half of Wisconsin physicians reporting burnout.
The report, based on a survey of 1,165 Wisconsin doctors, showed that nearly 53.5 percent are experiencing one symptom of burnout. And 47.1 percent plan to decrease clinical hours or retire early in the next five years.
“We continue to see higher percentages of physicians identifying one or more of the symptoms of burnout,” said society CEO Dr. Bud Chumbley. “That’s troublesome.”
The survey found that electronic health records were a top stressor for doctors, as well as government and insurance regulations and an unsupportive work environment.
To address burnout, Chumbley said that the society is planning to launch the Center for Physician Empowerment this year, which will seek to convene health systems in the state to share what they’re doing to address burnout efforts.
They’re also working on additional physician leadership and mentorship programs. Chumbley also said he's spoken with Verona-based Epic about the problem as well. He’s hoping to talk with insurers about their policies too.
“Our job is to identify these problems, try to get those individuals who can help solve them,” Chumbley said. “Hopefully, if we get all those people in a room, talking about how to solve it, that’s the best way to reverse this trend.”
The medical society is also working with the Medical Examining Board to develop legislation that would create a physician health program run by the state.
Chumbley said Wisconsin is one of the few states that doesn't have a physician health program. The society previously ran such a program, but it ended in 2007 due to "legal concerns and difficulties coordinating funding for the program," the report noted.
Marijuana was among the big winners at the polls in November, with voters in counties across the state signaling their support for legalization. Backers also have a friend in Gov.-elect Tony Evers, who has said doctors should be able to use cannabis to treat patients.
Meanwhile, CBD, a cannabis compound, has been heralded as a cure-all for everything from seizures to chronic pain to better sleep. Lawmakers have approved its use, but questions over its health benefits - and legality - remain.
A Jan. 8 Wisconsin Health News panel in Madison will take a closer look at the legal and health issues around marijuana and CBD – and their future in the state.
· Dr. Mike Miller, American Board of Addiction Medicine
· Michael Queensland, Senior Staff Attorney, Wisconsin Legislative Council
· Rep. Chris Taylor, D-Madison
· Sen. Pat Testin, R-Stevens Point
The Wisconsin Medical Society has urged the state’s Medical Examining Board (MEB) to be flexible when approving courses related to opioid prescribing so that more physicians can receive useful education befitting their particular specialties. The input was given at a public hearing before the MEB on a new administrative rule related to an extension of the opioid prescribing continuing medical education (CME) course requirement until November 2021.
Current rules require physicians holding a U.S. Drug Enforcement Administration number to complete two of the 30 required hours of CME per biennium in an MEB-approved course related to the state’s opioid prescribing guidelines. The current requirement expires in November 2019. The MEB is extending the requirement for another CME reporting biennium while broadening the subject matter scope to “an educational course or program related to opioid prescribing.”
The Society was the only organization to testify before the MEB on the rule proposal.
Flexibility in the types of courses that can gain MEB approval would make the requirement more relevant to certain physicians who, while not being active opioid prescribers, often take care of patients dealing with the aftermath of opioid addiction or abuse. The Society also suggested that the Board could incentivize physicians taking coursework in Medication Assisted Treatment (MAT) by making those courses eligible to satisfy the requirement should they be submitted for CME approval. The MEB welcomed the comments and indicated that such flexibility would be useful as Wisconsin continues to grapple with this issue.
The MEB unanimously approved the rule proposal, which now moves on to standard Governor’s office and legislative review. Contact Mark Grapentine, JD, for more information.
Each of the webinars available in the Society’s opioid prescribing series has been approved by the MEB for fulfilling the 2018-2019 CME requirement, including two 2-hour webinars presented by Michael McNett, MD. The other programs vary in length and may be combined to satisfy the mandate. Click here to learn more.
MCW-affiliated concussion study gets more backing
*From Wisconsin Health News, 11/9/2018
A consortium studying concussions that includes the Medical College of Wisconsin recently received $22.5 million in new funding, according to a statement.
The money from the Department of Defense and NCAA will expand a concussion study that includes MCW, Indiana University School of Medicine, the University of Michigan and the Uniformed Services University.
The NCAA-DOD Concussion Assessment, Research and Education Consortium has collected data on more than 39,000 student-athletes and cadets at 30 colleges and military service academies.
That includes 3,300-plus who have had concussions, the largest sample of concussions researched in a single study.
A $30 million joint NCAA-Department of Defense grant funded the first part of the study, which focused on the acute effects of concussions.
The new phase, funded by $12.5 million from NCAA and nearly $10 million from a DOD grant, will look at the intermediate and cumulative effects of concussion and repetitive head impacts.
"What we learn from this research will advance the science of traumatic brain injury and improve our understanding of how to best support the health and well-being of student-athletes, not only during their collegiate athletics experience but beyond,” Dr. Brian Hainline, NCAA chief medical officer, said in a statement.
The Wisconsin Neurological Society honors a long-standing tradition of recognizing resident research by holding an annual competition for the Francis M. Forster Research Award.
The featured Resident Presenters this year were:
Pediatric Stroke: A case report, review and management - Erica Tauck, MD, PGY III, University of Wisconsin Hospital and Clinics Neurology
Quantitative Analysis of Epileptic spikes using high density EEG: Differences between NREM and REM sleep
Xuan Kang, MD, University of Wisconsin – Department of Neurology
Seizure prophylaxis in the immediate post-hemorrhagic period in patients with aneurysmal subarachnoid hemorrhage
Salman Farooq, MD, Medical College of Wisconsin
Developing a process for IV tPA door-to-needle administration in 30 minutes or less, a multidisciplinary approach
Sumaiya Khondker, MD, Medical College of Wisconsin
The award is named for Francis M. Forster, MD, one of the founders of the American Academy of Neurology. He was considered an internationally-recognized expert in the diagnosis and treatment of epilepsy and a prominent neurologist.
October 19-20, 2018Osthoff Resort, Elkhart Lake, WI
2018 brought yet another successful annual conference for the Wisconsin Neurological Society! We had 45 neurological physicians, nurse practitioners, physician assistants, residents and others who practice in neurology in attendance. We also are proud to have a record breaking 30 exhibitors come to support the organization and display their technological advances in the field of neurology. Eight speakers presented on a vast array of neurological topics, as well as the traditional Forster Award Competition featuring four residents.
A special thank you to Dr. Jennifer Connelly, our CME Director for coordinating the presenters and educational activities. Our CME Sessions have had rave reviews with variations and advances in the field of neurology. If you have not had a chance to complete your evaluation, please be sure to do so in order to claim CME credit, also.
Our thanks to the following exhibitors for their support: Acadia Pharmaceuticals, Alexion Pharmaceuticals, Allergan Neurosciences, Alnylam, American Academy of Neurology, Amgen, Aspirus, Aurora Health Care, Avanir, Biogen, Boston Scientific Deep Brain Stimulation, Chiesi USA, EMD Serono, Froedtert and The Medical College of Wisconsin, Genentech, Greenwich Biosciences, Grifols Therapeutics, Impax, Lundbeck, Mayo Clinic Laboratories, Medtronic, Neurocrine Biosciences, Neurotech LLC, Novartis, Pfizer Inc, Sanofi Genzyme (2 tables), Teva Pharmaceuticals, UCB, and US Worldmeds.
Our appreciation to Dr. Terrence Cascino, Dr. Chad Carlson, Dr. Natalie Wheeler, Dr. Staley Brod, Dr. Fallon Schloemer, Dr. Kathleen Shannon and Dr. Eric Adelman for your contribution to the success of the conference by presenting to our attendees.
Special congratulations to our Bennett Hiner Award Winner - Brett Fulleylove-Krause.
563 Carter Court, Suite B, Kimberly, WI 54136
Phone: 920-560-5622 | Fax: 920-882-3655